STRENGTHS AND LIMITATIONS OF THIS STUDY
An international advisory panel, including clinicians and individuals with lived experience, is supporting the ongoing core outcome set (COS) development process to identify outcome measures relevant to arthrogryposis.
Representation from diverse healthcare and cultural contexts across Canada, the USA, Poland, Australia and India provides global perspectives on assessment priorities and the applicability of the COS across different settings.
Engagement of clinicians and individuals with lived experience throughout the COS development process supports the inclusion of outcomes that are meaningful to the broader arthrogryposis community.
Purposive and snowball sampling, as well as the availability of consensus-building materials only in French and English, may influence the diversity of perspectives captured.
Three hundred million people are affected by 1 of approximately 7000 rare diseases around the world.
This post was originally published on https://bmjopen.bmj.com